PAVmed released its financial presentation for the second quarter of 2026, indicating a narrowing net loss for the period. However, the company's financial documents also showed a corresponding decline in its overall cash position.
Additional details regarding specific revenues, operating expenses, and the exact magnitude of the cash decline were not immediately available in the preliminary release.
